Bavarian Nordic A/S

Two European pharmaceutical companies brought the first-quarter earnings season for big cap pharma companies to a close. Although there were hints at the pressures from the first quarter, they appeare

The European Medicines Agency has temporarily suspended the use of Valneva’s chikungunya vaccine, Ixchiq, in individuals over 65 years old following reports of serious adverse events in elderly people

The terms of the faceoff between the two US Food and Drug Administration-approved chikungunya vaccines shifted more favorably towards Bavarian Nordic ’s Vimkunya after the 16 April meeting of the US

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices sprinted through a condensed two-day schedule at its 15-16 April meeting, which originally had been planne